The Japanese Prime Minister shouted to Gilead: Give quick approval as soon as you submit the Ridsiewe application!

At present, the outbreak of new coronary pneumonia is still spreading around the world, as of 1300 hours on April 28, the cumulative number of confirmed cases worldwide has exceeded 3.06 millionThe world is eagerly awaiting the advent of special drugs, with the highest clamour for remdesvirAny trace of the drug is always touching the nervous nerves of the publicrecent years, NEJM's sympathetic drug data, early clinical data from the University of Chicago, and monkey trial data from the National Institutes of Health (NIH) have raised expectations for RedseyBut the World Health Organization's unexpected leak of China's test data in recent days has sparked widespread debate about the effectiveness of Redseyindustry sources point out that while the trial was not able to reach meaningful statistical conclusions due to an early end in the group of patients, the data showed no difference between Redciewe and placebo, and that there was little hope of successOthers, however, insist that Redsiewe is still worth the public's expectations, especially in early treatmentfor now, the discussions surrounding Redsey are continuingAccording to gilead's timeline, the first batch of open-label clinical data for patients with severe illness will be released by the end of April, and data from the double-blind placebo-controlled trial will be released by the end of MayAlthough the drug has yet to yield any clear clinical outcome, one country has expressed a willingness to quickly approve the listing of RedseyJapanese Prime Minister Shinzo Abe said Japan would soon approve Redsiewe to treat COVID-19 patients, according to Kyodo NewsAnother government official said separately that the drug could be approved as early as May for patients with COVID-19 to treat respiratory diseases caused by the new coronavirus, MrAbe said at a parliamentary meeting on Monday that MrReedsiwe's approval would soon become possibleThe Japanese government will quickly approve the drug to market as long as Gilead appliestypically, this streamlined process involves delaying reporting of data for clinical trials in Japan, but only if the drug is approved in another country In view of the current outbreak, the Government of Japan has decided to grant a special expedited approval for Redciway If it becomes a reality, it would be the first such approval by Japan during the pandemic, and Japan would become the first country in the world to approve Ridsey according to Baidu's Real-Time Big Data Report on the Outbreak of New Coronary Virus Pneumonia, a total of 13,614 cases have been confirmed in Japan, 10,314 cases have been confirmed and fewer than 400 deaths have been reported In recent weeks, however, the Japanese government has issued tougher blockades to stem the spread of the epidemic The Olympics, which were scheduled for this summer, have also been postponed until 2021 has yet to respond to the Japanese government's intention to quickly approve Redsey, with a spokesman for its Japan unit saying: "We are currently conducting clinical trials to confirm the effectiveness and safety of the drug." reference source: 1, Japan to approve remdesivir for coronavirus patients in may 2, Gilead's COVID-19 sydd remdesivir may get swift Japanese approval report: